Dr. Monica Bertagnolli nominated to lead NIH
F或立即释放
凯拉·梅斯特
703-836-1746
kyra.meister@preventcancer.org
Photo credit: National Cancer Institute
Alexandria, Va. – President Biden announced this week his intent to nominate Monica Bertagnolli, M.D., FACS, to be the next director of the National Institutes of Health (NIH). Dr. Bertagnolli is currently serving as the director of the National Cancer Institute, the largest agency in the NIH.
Dr. Bertagnolli has valuable firsthand experience as both a cancer surgeon and patient that will serve her well in this role. She was the Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology at Harvard Medical School and a member of the Gastrointestinal Cancer and Sarcoma Disease Centers at Dana-Farber Brigham Cancer Center.
In December 2022, Dr. Bertagnolli announced she had been diagnosed with breast cancer following a routine mammogram.
“It’s one thing to know about cancer as a physician, but it is another to experience it firsthand as a patient as well,” she said in a statement released at the time.
The Prevent Cancer Foundation has a long history with Dr. Bertagnolli, who was serving on the Foundation’s board of directors when she was selected as director of NCI. (In order to accept her role at NCI, Dr. Bertagnolli had to resign from all board positions.) She was also a member of the Prevent Cancer Foundation’s Medical Advisory Board. In 1997 and 2001, as a relatively junior researcher, Dr. Bertagnolli received funding from the Prevent Cancer Foundation to support young researchers in her lab.
“In our work with Dr. Bertagnolli, we have been able to see up close how committed she is to exploring innovative ideas, supporting early-career researchers, and keeping the patient top of mind. We know her dedication to the patient experience has only deepened after her own journey with cancer,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We applaud President Biden for selecting Dr. Bertagnolli for this prestigious appointment and urge a quick nomination and confirmation process so she can begin the process of leading the NIH.”
In 2021, President Biden reignited the Cancer Moonshot, with ambitious goals to reduce the death rate from cancer by at least 50% over the next 25 years, improve the experience of people and their families living with and surviving cancer and ultimately “end cancer as we know it.” Dr. Bertagnolli has already made great strides in advancing President Biden’s Cancer Moonshot during her time as director of the NCI. The president’s intent to nominate Dr. Bertagnolli to lead the NIH will benefit patients and their families while ushering in a new era of innovation in oncology and across the entire health care continuum.
After President Biden’s nomination, Dr. Bertagnolli will need to be confirmed by the Senate. She would be only the second woman to lead the NIH on a permanent basis.
###
关于预防癌症基金会®
预防癌症基金会® 是 唯一的美国-基于 非盈利机构 独自 投入的 到 癌症 预防和早期 检测. 通过研究、教育、 外展 和倡导, 我们已经帮助无数人避免癌症诊断或及早发现癌症并得到成功治疗。 我们受到 一个可以预防癌症的世界的愿景， 可检测 并且可击败 对全部.
基金会正努力应对到 2035 年减少 40% 癌症死亡人数的挑战。为了实现这一目标， 我们是 承诺投资 $2000 万美元用于创新技术，以尽早发现癌症并推进 多-癌症筛查，$1000万美元用于扩大癌症筛查和疫苗接种覆盖面 医学上 服务不足的社区，并投入 $10 万美元用于教育公众了解筛查和疫苗接种选择。
如需了解更多信息，请访问 www.preventcancer.org.